Introduction: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed cause of AHF that benefits from a specific approach. The aim was to determine the prevalence of ATTR-CM among patients hospitalized for AHF.
Methods: A prospective study was conducted on consecutive patients aged 60 or older admitted for acute AHF without cardiogenic shock.